MSCLF Message Board Post 10722948 | iCo Therapeutics
home / stock / msclf / msclf message board
Sofia
(investorshangout)
Posted on: Jul/16/2014 08:58:52
Source: investorshangout
https://investorshangout.com/post/view?id=1663790
Emylers: ICOTF Financials 07/16/2014 03:58:55 Ico Therapeutics, Inc. Period Ending Dec 31, 2013 Dec 31, 201
News, Short Squeeze, Breakout and More Instantly...
-
– Investigational New Drug (IND) enabling preclinical and toxicology studies successfully completed – Initiation of a Phase 1 clinical trial of SAT-3247 anticipated in Q3 2024 Satellos Bioscience Inc. (“Satellos” or the “Company”) ...
-
–SAT-3247 treatment improved muscle repair and regeneration in canine model of DMD – SAT-3247 treatment also improved muscle force in this canine model of DMD – Satellos remains on track to initiate a Phase 1 clinical trial in Q3 2024 Satellos Bios...
-
– Frank Gleeson, Satellos CEO, to participate in a panel discussion titled "Research Row: PPMD Moving the Needle" on June 29, 2024 – Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSX: MSCL, OTCQB: MSCLF), a public biotech company d...